Komori
GMO Payment Gateway (3769) · InitiativeReframed

Making GMO Medical Reservation Technology Research Institute a Subsidiary

First written in FY2018. 2 of 4 entries say "Advanced", first in FY2022. Latest entry: FY2025-H1.

4entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2018AdvancedFY2022 – FY2023-Q32018: 12019: 020192020: 020202021: 020212022: 120222023: 120232024: 020242025: 12025
Same theme, other companies
Strengthening the medical appointment services platform through the acquisition of GMO医療予約技術研究所 as a subsidiaryA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2025-H1ReframedAnnual report

    「GMO Medical Reservation Technology Research Institute Co., Ltd. changed its corporate name to GMO Reserve Plus Co., Ltd. effective 14 February 2025.」

    The corporate name of the consolidated subsidiary providing medical appointment services changed to GMO Reserve Plus Co., Ltd. effective 14 February 2025.
  2. FY2023-Q3AdvancedAnnual report

    「Revenue performed strongly, increasing 37.0% year on year, driven partly by growing demand for services provided by GMO Medical Reservation Technology Research Institute Co., Ltd. that enable users to make appointments, complete medical questionnaires, check in and make payments through a smartphone app, as well as consolidate the appointment cards of multiple medical institutions into a single smartphone.」

    Revenue from GMO Medical Reservation Technology Research Institute’s smartphone-based medical appointment, check-in and payment services increased 37.0% year on year.
  3. FY2022AdvancedAnnual report

    「GMO Medical Reservation Technology Research Institute Co., Ltd. provides services that allow users to make appointments, complete medical questionnaires, check in and make payments through a smartphone app, as well as consolidate the appointment cards of multiple participating medical institutions into a single smartphone. In the current fiscal year, revenue increased 78.4% year on year, driven partly by increased demand resulting from the spread of COVID-19, as in the previous fiscal year.」

    Revenue from services enabling users to make medical appointments, complete medical questionnaires, check in and make payments by smartphone increased 78.4% year on year.
  4. FY2018First statedAnnual report

    「August 2018: GMO Medical Reservation Technology Research Institute Co., Ltd. became a subsidiary through GMO Epsilon Co., Ltd. (currently a consolidated subsidiary).」

    In August 2018, GMO Medical Reservation Technology Research Institute became a subsidiary through GMO Epsilon.
Moved together

"Growing Adoption of Card Payments for Remote Transactions and Everyday Needs" moved the same way as this thread, in the same document, in 2 of its 4 moves.

222222★123456
  1. ★This thread
  2. 1Growing Adoption of Card Payments for Remote Transactions and Everyday Needs2×
  3. 2Growth in Payment Transaction Volume and Value2×
  4. 3High Growth in Sales and Profit2×
  5. 4Growth in financial services revenue and a return to profitability2×
  6. 5Expansion of the in-person payments market through the acquisition of GMO Financial Gate as a subsidiary2×
  7. 6Rollout of the Next-Generation Payment Platform “stera”2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for GMO Payment Gateway yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Making GMO Medical Reservation Technology Research Institute a Subsidiary | GMO Payment Gateway,Inc. (3769) | Komori